Immune Activation in Primary Human Immunodeficiency Virus: Influence of Duration of Infection, Treatment, and Substance Use.

Trupti GiladaSamuel R SchnittmanEdward WhiteJacqueline MercaderYixin WangSayan DasguptaRogelio ValdezDelia Pinto-SantiniSiavash PasalarJorge SanchezPedro GonzalesJavier R LamaRachel Bender IgnacioAnn Duerr

Published in: Open forum infectious diseases (2022)

cell counts and a trend toward higher soluble CD163 levels during the 30 days after acquisition suggest the onset of compensatory responses and immune exhaustion.

Keyphrases

human immunodeficiency virus
hepatitis c virus
antiretroviral therapy
hiv infected
single cell
cell therapy
hiv positive
peripheral blood
stem cells
combination therapy
bone marrow
mesenchymal stem cells